Roper Saint Francis Physicians Network
Roper Saint Francis Physicians Network was paid $1.25M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 13% of everything it billed.
NORTH CHARLESTON, SC 29405
Next to other Clinical Medical Laboratory providers in South Carolina
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,436 | $131K | |
| 2019 | 15,717 | $145K | |
| 2020 | 20,070 | $152K | |
| 2021 | 22,457 | $211K | |
| 2022 | 27,639 | $296K | |
| 2023 | 24,763 | $171K | |
| 2024incomplete | 23,227 | $148K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 13% | 13,392 | 12,457 | $166K |
| 80053 | Comprehensive metabolic panel | 12% | 18,566 | 17,159 | $146K |
| 80061 | Lipid panel | 9.3% | 12,342 | 11,485 | $117K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9.2% | 1,196 | 1,124 | $116K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 7.1% | 4,722 | 4,338 | $89K |
| 83036 | Hemoglobin; glycosylated (A1C) | 7.1% | 12,240 | 11,484 | $89K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.5% | 13,812 | 12,666 | $81K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.8% | 3,908 | 3,643 | $73K |
| 85027 | 3.3% | 8,166 | 7,588 | $41K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.9% | 267 | 251 | $37K |
| 82728 | 2.3% | 2,891 | 2,691 | $29K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.2% | 900 | 827 | $28K |
44 more codes
| 82607 | 2.0% | 2,370 | $24K | |
| 87340 | 1.9% | 2,916 | $24K | |
| 84439 | 1.7% | 3,527 | $21K | |
| 86762 | 1.6% | 1,798 | $21K | |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 20,032 | $19K |
| 83550 | 1.2% | 2,430 | $15K | |
| 86803 | 1.1% | 1,425 | $14K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 2,320 | $14K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.0% | 962 | $13K |
| 83540 | <1% | 2,660 | $12K | |
| 86592 | <1% | 3,280 | $12K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 924 | $12K |
| 82746 | <1% | 816 | $8K | |
| 82950 | <1% | 1,599 | $6K | |
| 82043 | <1% | 1,141 | $4K | |
| 82570 | <1% | 1,017 | $3K | |
| 84702 | <1% | 206 | $2K | |
| 83735 | <1% | 449 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 390 | $2K |
| 80076 | <1% | 321 | $2K | |
| 81001 | <1% | 747 | $2K | |
| 86140 | <1% | 361 | $1K | |
| 84481 | <1% | 94 | $1K | |
| 85045 | <1% | 269 | $808.26 | |
| 85652 | <1% | 347 | $762.40 | |
| 80074 | <1% | 59 | $754.38 | |
| 81003 | <1% | 431 | $739.80 | |
| 83970 | <1% | 25 | $653.20 | |
| 83690 | <1% | 124 | $600.06 | |
| 84153 | <1% | 42 | $505.82 | |
| 86706 | <1% | 34 | $401.82 | |
| 83001 | <1% | 27 | $381.36 | |
| 85610 | <1% | 89 | $267.39 | |
| 82670 | <1% | 12 | $246.94 | |
| 86850 | <1% | 28 | $192.01 | |
| 84144 | <1% | 12 | $167.22 | |
| 84146 | <1% | 12 | $154.99 | |
| 83880 | <1% | 12 | $148.51 | |
| 86901 | <1% | 28 | $65.26 | |
| 86900 | <1% | 28 | $65.26 | |
| 84132 | <1% | 16 | $43.47 | |
| 80050 | General health panel | <1% | 270 | $4.89 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 243 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.